Table 3.

Psychotropic medications in subjects with bipolar disorder

Medication	Baseline (n=47)	1 year (n=37)	2 year (n=30)
Antidepressants (SSRIs, SNRIs, etc.)	31 (66.0)	25 (67.6)	24 (80.0)
Antipsychotics (novel or conventional)	12 (25.5)	13 (35.1)	10 (33.3)
Anticonvulsants (divalproex, carbamazepine or lamotrigine)	20 (42.6)	16 (43.2)	17 (56.7)
Benzodiazepines (lorazepam, clonazepam, etc.)	16 (34.0)	12 (32.4)	13 (43.3)
Cognitive enhancer (cholinesterase inhibitor or memantine)	4 (8.5)	6 (16.2)	4 (13.3)
Lithium	12 (25.5)	10 (27.0)	6 (20.0)
Sedative-hypnotics (trazodone, zaleplon or zolpidem)	8 (17.0)	5 (13.5)	5 (16.7)
Stimulants (dexedrine, methylphenidate or modafinil)	2 (4.3)	3 (8.1)	3 (10.0)

Data are given as number of subjects (%).

SSRIs, Selective serotonin reuptake inhibitors; SNRIs, serotonin–norepinephrine reuptake inhibitors.